Cargando…
Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections
(1) Background: COVID-19 vaccine effectiveness should be carefully evaluated and explicitly defined. To our knowledge, this is the first report to quantitatively evaluate humoral responses post 3 doses of SARS-CoV-2 immunization and prior to breakthrough COVID-19 infection in Canadian cancer patient...
Autores principales: | Macrae, Kathryn, Martinez-Cajas, Jorge, Bessai, Kristin, Abdulhamed, Abulhameed, Gong, Yanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599995/ https://www.ncbi.nlm.nih.gov/pubmed/36290831 http://dx.doi.org/10.3390/curroncol29100554 |
Ejemplares similares
-
Quantitative Analysis of SARS-CoV-2 Serological Responses Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections
por: Macrae, Kathryn, et al.
Publicado: (2022) -
Evaluation and comparison of four quantitative SARS-CoV-2 serological assays in COVID-19 patients and immunized healthy individuals, cancer patients, and patients with immunosuppressive therapy
por: Chan, Agnes, et al.
Publicado: (2023) -
Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection
por: Goto, Takeyuki, et al.
Publicado: (2022) -
Quantitative Analysis of SARS-CoV-2 Antibody Status between Patients with Cancer and Healthy Individuals with Extended Vaccination Dosing Intervals in Canada
por: Robinson, Andrew, et al.
Publicado: (2021) -
AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection
por: Aksyuk, Anastasia A., et al.
Publicado: (2022)